Page last updated: 2024-08-25

guanoxabenz and allopurinol

guanoxabenz has been researched along with allopurinol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dambrova, M; Uhlén, S; Welch, CJ; Wikberg, JE1
Dambrova, M; Oliver, DW; Tiger, G; Uhlén, S; Wikberg, JE1
Dambrova, M; Prusis, P; Uhlén, S; Welch, CJ; Wikberg, JE1
Dambrova, M; Uhlén, S; Wikberg, JE1
Cirule, H; Dambrova, M; Kalvinsh, I; Meirena, D; Veveris, M; Wikberg, JE1

Other Studies

5 other study(ies) available for guanoxabenz and allopurinol

ArticleYear
Identification of an N-hydroxyguanidine reducing activity of xanthine oxidase.
    European journal of biochemistry, 1998, Oct-01, Volume: 257, Issue:1

    Topics: Animals; Catalysis; Cattle; Guanabenz; Guanidines; Hydroxylamines; Kinetics; Milk; NAD; Oxidation-Reduction; Oxygen; Rats; Xanthine Oxidase

1998
Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. I. Description of an enzymatic activity in spleen membranes.
    Biochemical pharmacology, 1998, Nov-01, Volume: 56, Issue:9

    Topics: Animals; Antihypertensive Agents; Binding, Competitive; Cerebral Cortex; Guanabenz; Idazoxan; Magnesium; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spleen; Xanthine Oxidase

1998
Characterization of the enzymatic activity for biphasic competition by guanoxabenz (1-(2,6-dichlorobenzylidene-amino)-3-hydroxyguanidine) at alpha2-adrenoceptors. II. Description of a xanthine-dependent enzymatic activity in spleen cytosol.
    Biochemical pharmacology, 1998, Nov-01, Volume: 56, Issue:9

    Topics: Allopurinol; Animals; Antihypertensive Agents; Binding, Competitive; Cytosol; Guanabenz; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spleen; Xanthine; Xanthine Oxidase

1998
Characterization of guanoxabenz reducing activity in rat brain.
    Pharmacology & toxicology, 1998, Volume: 83, Issue:4

    Topics: Allopurinol; Animals; Antihypertensive Agents; Binding, Competitive; Cerebral Cortex; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Guanabenz; Male; NAD; NADP; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Synaptic Membranes; Xanthine

1998
Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.
    British journal of pharmacology, 1999, Volume: 128, Issue:5

    Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Cardiovascular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanabenz; Guanidines; Hydroxylamines; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidation-Reduction; Rats; Rats, Wistar; Reperfusion Injury; Xanthine Oxidase

1999